Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator].

Medecine sciences : M/S - 1 Oct 2013

Prudent Renaud, Soleilhac Emmanuelle, Barette Caroline, Fauvarque Marie-Odile, Lafanechère Laurence

Abstract excerpt

Phenotypic screens, in which chemical libraries are assayed on cells with the aim to isolate compounds that interfere with a given cell function, are a risky but powerful strategy to discover, in the same approach, new therapeutic targets and the compounds able to regulate them. With a strong experience of nearly 10 years in the field, we present the advantages of such an approach, the possible troubles and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Cell Image Analysis Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to France

Share to High-Throughput Screening Assays

Share to Molecular Targeted Therapy

Share to Phenotype

Share to Small Molecule Libraries

Source

Identifiers

PMID: 24148129
DOI: 10.1051/medsci/20132910018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator].PMID 24148129Read ↗

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.Semantic proximity Read ↗

Bridging the gap between target-based and phenotypic-based drug discovery.Semantic proximity Read ↗

Phenotypic screening: A more rapid route to target deconvolution.Semantic proximity Read ↗

[Modern genetic approaches to the search for targets for medicinal preparations].Semantic proximity Read ↗

Design of phenotypic screens for bioactive chemicals and identification of their targets by genetic and proteomic approaches.Semantic proximity Read ↗

How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.Semantic proximity Read ↗

Computational analyses of small molecules activity from phenotypic screensSemantic proximity Read ↗

The why and how of phenotypic small-molecule screens.Semantic proximity Read ↗

Finding the target after screening the phenotype.Semantic proximity Read ↗

Screening and identification of novel biologically active natural compoundsSemantic proximity Read ↗

Phenotypic screens as a renewed approach for drug discovery.Semantic proximity Read ↗

The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.